4694

BML, INC.

株式会社ビー・エム・エル
Services
BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing. It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds. In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.
← Companies
Price
¥3,485
Market Cap
¥135.9B
Ent. Value
Net Cash est
Shares Out.
39.0M
P / E
21.7×
EV / EBIT
P / Book
1.05×
P / NCAV
2.32×
Div. Yield
3.44%
Financials
Metric FY 2024
EDINET ↗
FY 2023
EDINET ↗
FY 2022
EDINET ↗
FY 2021
EDINET ↗
Net Sales ¥143.2B ¥138.0B ¥159.5B ¥186.1B
Cost of Sales ¥97.3B ¥92.3B ¥98.0B ¥99.1B
Gross Profit ¥45.9B ¥45.6B ¥61.4B ¥87.0B
SG&A ¥36.5B ¥36.5B ¥37.5B ¥38.1B
Operating Income ¥9.4B ¥9.2B ¥23.9B ¥48.9B
Non-Operating Income ¥776M ¥651M ¥500M ¥2.3B
Dividend Income ¥290M ¥229M
Non-Operating Expenses ¥170M ¥213M ¥254M ¥104M
Interest Expense ¥118M ¥104M ¥40M ¥36M
Ordinary Income ¥10.0B ¥9.6B ¥24.2B ¥51.1B
Pre-tax Income ¥9.7B ¥9.5B ¥24.2B ¥50.3B
Income Taxes ¥3.2B ¥3.3B ¥8.0B ¥15.7B
Current Tax ¥3.2B ¥3.2B ¥7.2B ¥15.8B
Deferred Tax ¥-23M ¥41M ¥846M ¥-195M
Net Income (owners) ¥6.3B ¥6.0B ¥15.6B ¥33.7B
Minority Interest ¥245M ¥228M ¥578M ¥937M
Comprehensive Income ¥7.2B ¥7.6B ¥15.4B ¥34.7B
EBITDA ¥17.1B ¥16.0B ¥30.3B ¥54.8B
Goodwill Amort. (J-GAAP) ¥91M ¥91M ¥91M
EPS ¥160.62 ¥154.81 ¥395.84 ¥833.24
Shares Outstanding 39.0M 39.0M 39.0M 39.9M
Shares Issued (total) 42.3M 42.3M 42.6M 43.5M
Treasury Shares 3.3M 3.3M 3.6M 3.6M